BeiGene Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG1146Y1017
HKD
194.50
4.8 (2.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
WuXi AppTec Co., Ltd.
China Medical System Holdings Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd.
Innovent Biologics, Inc.
Akeso, Inc.
HUTCHMED (China) Ltd.
BeiGene Ltd.
Why is BeiGene Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
  • Poor long term growth as Operating profit has grown by an annual rate 16.19% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -83.25
2
The company has declared negative results in Dec'2023 after 4 consecutive positive quarters
  • PBT LESS OI(Q) At HKD -3,036 MM has Fallen at -17.0 %
  • PAT(Q) At HKD -2,914 MM has Fallen at -53.0 %
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 75.23%, its profits have risen by 74.3%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is BeiGene Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
BeiGene Ltd.
78.93%
1.98
52.44%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
79.78%
EBIT Growth (5y)
16.19%
EBIT to Interest (avg)
-83.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.27
Tax Ratio
45.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.86
EV to EBIT
-316.93
EV to EBITDA
356.28
EV to Capital Employed
16.05
EV to Sales
6.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.06%
ROE (Latest)
-4.24%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for BeiGene Ltd.
Net Sales - Half Yearly
At HKD 11,070.54 MM has Grown at 84.04 %
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Operating Cash Flow - Annually
Highest at HKD -9,061.63 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Here's what is not working for BeiGene Ltd.
Profit Before Tax less Other Income (PBT) - Quarterly
At HKD -3,036 MM has Fallen at -17.0 %
over average PBT of the previous four periods of HKD -2,594 MM
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (HKD MM)

Profit After Tax (PAT) - Quarterly
At HKD -2,914 MM has Fallen at -53.0 %
over average PAT of the previous four periods of HKD -1,905 MM
MOJO Watch
Near term PAT trend is very negative

PAT (HKD MM)